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Brain Water Diffusion in Normal and
Creatine-Supplemented Rats During
Transient Global Ischemia
Markus Wick, Hiroyuki Fujimori, Thomas Michaelis,* and Jens Frahm
Brain water diffusion in response to transient global ischemia
(12 min), reperfusion (60 min), and cardiac arrest was monitored
by localized proton magnetic resonance spectroscopy. The
trace of the apparent diffusion coefficient tensor (ADCAv) was
determined at high temporal resolution (10 sec) to assess the
putative neuroprotective potential of oral creatine (Cr) in rats
that received 2.2 g Cr-monohydrate per kg body weight per day
for 10 days (n 5 8) relative to controls (n 5 9). Cr-fed rats
revealed a statistically significant increase of the cerebral
concentration ratio of Cr to choline-containing compounds
(20%). The decrease of the ADCAv value during acute ischemia
showed a three-phasic behavior in line with energy depletion,
cytotoxic edema, and brain cooling. In Cr-fed rats, slightly less
severe and mildly delayed diffusion changes during ischemia
and similar beneficial trends during early reperfusion did not
reach statistical significance. Magn Reson Med 42:798–802,
1999. r 1999 Wiley-Liss, Inc.
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Animal studies have linked elevated brain creatine (Cr)
and phosphocreatine (PCr) to neuroprotection. For ex-
ample, in hippocampal slices, the availability of Cr was
shown to yield enhanced PCr levels and reduced neuronal
death under hypoxic stress most likely caused by a delayed
decrease of adenosine triphosphate (ATP) (1–3). Under in
vivo conditions, localized magnetic resonance spectroscopy
(MRS) revealed increases of total brain creatine (tCr) levels
after oral supplementation of Cr-monohydrate in both rats
(4–6) and humans (7). In addition, at least a partial protec-
tion of the brain against an impairment of energy metabo-
lism was demonstrated in an animal model of Hunting-
ton’s disease (5) as well as in hypoxic immature rats (6).
In a preceding proton MRS study of Cr supplementation
in a rat model of transient global ischemia, the time courses
of cerebral metabolite concentrations such as lactate (Lac)
and glucose (Glc) revealed no differences between Cr-fed
rats and controls on a time scale of minutes (4). Complemen-
tary, diffusion-weighted MRS (8,9) and MRI (10,11) of
brain water allows monitoring of ischemia-induced alter-
ations of the apparent diffusion coefficient (ADC) at a
temporal resolution of up to 10 sec. The diffusion sensitiv-
ity is generally ascribed to the occurrence of cytotoxic cell
swelling (cytotoxic edema) which results from the depolari-
sation of cell membranes and an osmotically driven influx
of water. The underlying loss of normal cell ion homeosta-
sis is caused by a failure of the plasma membrane ion
pumps which in turn reflects the loss of ATP within
regions of severely reduced blood flow (12).
The purpose of this work was to determine whether the
rapid diffusion changes following transient global isch-
emia and cardiac arrest are modulated or even alleviated
by oral administration of Cr using high-speed determina-
tions of the trace of the ADC tensor, i.e., ADCAv. The study
was based on the hypothesis that elevated Cr/PCr levels
may delay and/or attenuate the decrease of brain ATP
levels and therefore stabilize the energy metabolism during
the early stages of ischemia. A preliminary account has
been given in abstract form (13).
MATERIALS AND METHODS
Studies of male Wistar rats were performed in accordance
with German animal-protection laws and approved by the
responsible governmental authority. The Cr-fed group
(n 5 8, 315 6 26 g) received Cr-monohydrate (Sigma Chemi-
cal Co., St. Louis, MO) in their feed at a dose of 2.23 6 0.12
g per kg body weight per day (0.5% in water, 2.0% in
rodent chow) for 10 days, whereas control animals (n 5 9,
319 6 50 g) were on a normal diet.
Cr-fed rats and controls underwent a protocol consisting
of water-suppressed localized proton MRS of cerebral
metabolites and subsequent dynamic determinations of
ADCAv values obtained from the unsuppressed water sig-
nal. Diffusion measurements (100 min) were performed
before (10 min) and during transient global ischemia
(12 min, four-vessel occlusion model), during reperfu-
sion (60 min), and after cardiac arrest (18 min, KCl
injection). Details of the experimental setup, surgical pro-
cedure, anesthesia and ventilation, reversible occlusion,
and physiologic monitoring were as previously described
(4). In particular, there were no statistically significant
differences in arterial PO2, PCO2, pH, mean blood pres-
sure, and plasma Glc level between Cr-fed rats and con-
trols (unpaired t test) or before and after ischemia (paired t
test).
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MR measurements were carried out at 2.35 T using a
MRBR 4.7/400 mm magnet (Magnex Scientific, Abingdon,
England) and a 100 mT · m21 B-GA20 gradient system
driven by ABX-11 electronics (Bruker, Karlsruhe, Ger-
many). Radiofrequency excitation and signal reception
were accomplished by a 14-cm Helmholtz coil and a 2-cm
surface coil, respectively. Localized short echo-time proton
MR spectra (STEAM, TR/TE/TM 5 6000/20/10 msec) were
acquired from a 0.245 ml (7 3 5 3 7 mm3) volume of
interest (VOI) centrally placed in the cortex. Metabolite
quantification involved fully automated and user-indepen-
dent spectral evaluation by LCModel and calibration with
respect to the brain water concentration (4).
Diffusion-weighted proton MRS (STEAM, TR/TE/
TM 5 1000/140/10 msec) of the water signal from the same
VOI was performed at high temporal resolution (10 sec)
using three pairs of nonoverlapping bipolar lobes of orthogo-
nal gradients with the same polarity. Diffusion gradients
were placed symmetrically around the TM period to
ensure single-shot isotropic diffusion weighting as pro-
posed by Mori and van Zijl (14). The MRS implementation
avoids any cross talk between localization and diffusion
gradients, i.e., transverse magnetizations are fully refo-
cused before and after the diffusion weighting periods and
the effects of background gradients are automatically com-
pensated. To minimize contributions from restricted diffu-
sion, both the gradient duration d and the diffusion time D
between corresponding gradient lobes were adjusted to d 5
D 5 10 msec. Respirator-triggered acquisitions of brain
water diffusion were based on 10 spectra with variable
gradient strengths of up to 90 mT · m21. Pertinent measure-
ments were obtained continuously during the entire proto-
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from the strength of the water signal in the time domain
(10-Hz line broadening) in accordance to the Stejskal-
Tanner equation
A 5 A0 exp(2bAv · ADCAv) [2]
bAv 5 ng2G2d21D 2 13 d2 [3]
with A the measured signal strength at diffusion gradient
strength G, A0 the signal at zero gradient strength, n the
number of bipolar gradient pairs (n 5 6), and g the magneto-
gyric ratio. Apart from the diffusion weighting of the
localization gradients (173 sec · mm22), the isotropic bAv
values were 97, 218, 387, 605, 872, 1186, 1550, 1749, 1961,
and 2185 sec · mm22.
Online calculations of ADCAv values were done using a
modified Levenberg-Marquard algorithm (IMSL-C Numeri-
cal Libraries Version 1.02, Visual Numerics, Inc., Houston,
Texas). The ADCAv time course was continuously dis-
played (Gnu-Plot, version 3.5, C. Kelley, T. Williams) to
confirm a successful occlusion of the carotid arteries by a
corresponding ADCAv decrease.
RESULTS
Figure 1 compares mean proton MR spectra of rat brain in
vivo from Cr-fed rats and controls. The visible trends
toward elevated tCr (7%) and myo-inositol (Ins, 8%) are
confirmed when using concentration ratios with reference
to choline-containing compounds (Cho). In line with previ-
ous findings (4), Cr-fed rats revealed statistically signifi-
cant increases (unpaired t tests) of tCr/Cho (20%) and
Ins/Cho (24%).
Mean time courses of the ADCAv in response to transient
global ischemia (hashed bar), reperfusion, and cardiac
arrest (black bar) are shown in Figure 2 for both Cr-fed rats
and controls. The observed ADCAv reductions during isch-
emia (and after cardiac arrest) and its recovery during
reperfusion were very similar in both groups. The slightly
smaller decrease of the ischemic ADCAv value in the Cr
group was statistically not significant. These findings are
supported by the quantitative data summarized in Table 1.
Whereas the mean ADCAv values for Cr-fed rats and con-
trols are almost identical before and 50–60 min after
ischemia, the percentage reductions DADCAv after 12 min
of ischemia and cardiac arrest are slightly less pronounced
in Cr-fed rats.
FIG. 1. Mean brain spectra of (a) Cr-fed rats (n 5 8) and (b) controls
(n 5 9) obtained by localized proton MRS (STEAM, TR/TE/
TM 5 6000/20/10 msec, 0.245 mL VOI, 32–64 accumulations per
animal). Metabolites include N-acetylaspartate (NAA), total creatine
(tCr), choline-containing compounds (Cho), and myo-inositol (Ins).
Before averaging across animals the individual spectra were scaled
in absolute units in proportion to the brain water concentration.
Diffusion Changes in Ischemic Brain of Creatine-Fed Rats 799
Details of the temporal evolution of diffusional changes
are depicted in Figure 3. In particular, the ADCAv responses
to transient ischemia may be characterized by three phases
(I–III) and respective transition times (t1, t2). Phase I lasts
for about 1.5 min and accounts for about 20% of the total
ADCAv reduction. It consists of an initial drop within the
first 20–30 sec after occlusion and a somewhat slower
diffusion change thereafter. The major part of the ADCAv
reduction occurs during phase II and corresponds to about
60% of the total decrease. It may be described by an
exponential decay during a period of approximately 2.5
min. The almost linear ADCAv decrease during phase III
starts at 3.9 min after the onset of ischemia and contributes
about 20% of the total change.
To quantify the dynamic diffusion changes, the ADCAv
time courses were fitted by the superposition of a monoex-
ponential and a linear decay representing phases II and III.
The transition time t1 between phases I and II is defined by
the minimum difference between the model and the diffu-
sion data, whereas the transition time t2 between phases II
and III corresponds to the 5% level of the exponential
decay. Pertinent values as well as decay time constants are
summarized in Table 2. Changes between groups were not
statistically significant. However, the transition from phase
I to II as well as the time constant for the major ADCAv
decay during acute ischemia were slightly prolonged in the
Cr-fed group (23% increase of t1, 10% increase of the decay
time constant during phase II). This is also shown in Fig. 3,
which compares mean ADCAv time courses for Cr-fed rats
and controls.
During 60 min of reperfusion ADCAv values returned to
preischemic levels in all cases. In fact, recovery was
completed in shorter time periods as indicated by the 90%
recovery time t90 given in Table 2. Although the mean time
courses of the ADCAv shown in Fig. 3 do not reveal major
differences between Cr-fed rats and controls, they suggest a
slightly faster renormalization in the Cr-fed group during
early reperfusion. This observation is supported by the
50% recovery time t50 given in Table 2. Again, differences
between both groups were not statistically significant.
DISCUSSION
Although at the expense of high spatial resolution, the use
of isotropically diffusion-weighted localized proton MRS
of brain water yields quantitative determinations of the
trace of the diffusion tensor at high temporal resolution
and with excellent signal to noise. In fact, the present data
are characterized by a very low interindividual variation
and correspondingly small SD (Table 1). The ADCAv values
before ischemia and after reperfusion are in close agree-
ment with results reported for cat and rat brain (9–11).
Unfortunately, a more detailed comparison of absolute
values as well as of changes during ischemia with literature
findings is hampered by differences in diffusion times,
FIG. 2. Mean time courses of the trace of the brain water apparent
diffusion coefficient tensor ADCAv (mean 6 SD) in response to
transient global ischemia (hatched bar), reperfusion, and cardiac
arrest (solid bar) for (a) Cr-fed rats (n 5 8) and (b) controls (n 5 9).
The difference between Cr-fed rats and controls (c) is enlarged
fivefold. The temporal resolution of the ADC determinations is 10 sec.
Table 1
Mean Values of the Trace of ADCAv of Brain Water





ADCAv (1029 m2 · sec21)
Before ischemia 0.78 6 0.03 0.78 6 0.02
After 50–60 min of reperfusion 0.79 6 0.02 0.79 6 0.03
D ADCAv (%)
After 12 min of ischemia 230.0 6 1.9 227.3 6 4.5
12 min after cardiac arrest 235.0 6 1.4 233.5 6 1.7
*Data given as means 6 SD. ADCAv values of individual animals
represent time averages (9 min) obtained immediately before tran-
sient global ischemia and cardiac arrest, respectively. D ADCAv
values denote the maximum ADCAv decrease after 12 min of
transient ischemia or cardiac arrest. Differences between groups
were not statistically significant (unpaired t tests: Cr-fed rats vs.
controls).
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orientation of the diffusion gradients, brain regions, and
species.
The temporal evolution of ADCAv changes in response to
acute ischemia as well as after cardiac arrest exhibits a
multiphasic behavior in agreement with previous observa-
tions by others (8–11). Thus, the early diffusion changes
may be quantified in terms of transition times and decay
time constants for a model comprising three phases of
pathophysiologic events. Phase I is generally assumed to
reflect the early breakdown of oxidative metabolism. For
example, by use of biochemical methods it has been
reported that both PCr and ATP pools are depleted after
approximately 90 sec of ischemia in adult rats (15). This
timing is in excellent agreement with the t1 values obtained
here (Table 2) for the transition of phase I to II. It further
coincides with the timing reported for the increase of
extracellular K1 concentrations accompanying anoxic de-
polarization (16,17). The subsequent strong ADCAv reduc-
tion during phase II (,2.5 min) parallels the shift of
extracellular to intracellular water after the breakdown of
energy supply and ion homeostasis. During phase III, i.e.,
3.9 min after the onset of ischemia, the occurrence of a
further but slower ADCAv decrease must be ascribed to
brain cooling leading to a continuously decreasing tissue
temperature (18).
During reperfusion ADCAv values start to increase within
a few seconds after the release of the balloon occluders.
This observation is consistent with the immediate inflow
of warm blood into the brain and a rapid recovery of the
cerebral blood oxygenation. Both effects should account
for a total ADCAv increase by approximately 40% of the
DADCAv value. A further increase should result from the
normalisation of the K1 concentration, which is completed
within 4–5 min (16,17). Typical recovery times are 1.5–1.8
min (50%) and approximately 8 min (90%), whereas full
return to mean preischemic values requires 30–40 min
(compare Fig. 2). Normalisation of the cerebral PCr/ATP
ratio has been reported to take approximately 24 min after a
15-min period of transient global ischemia (19).
Although diffusion changes after cardiac arrest follow
the same pattern as during acute global ischemia, they are
slightly more pronounced (DADCAv in Table 1) and faster (t1
and t2 in Table 2). This may be explained by the fact that
transient ischemia—in contrast to cardiac arrest—retains
beneficial effects from residual collateral blood flow and a
lower degree of brain cooling as a result of the isolating
effect of the perfused skull.
FIG. 3. Expanded mean time courses of the trace of the brain water
apparent diffusion coefficient tensor ADCAv in response to (a) transient
global ischemia, (b) reperfusion, and (c) cardiac arrest for Cr-fed rats
(solid lines) and controls (dashed lines). The transition times (t1, t2)
and recovery times (t50, t90) characterize the multiphasic diffusion
changes during ischemia (and cardiac arrest) and reperfusion, respec-
tively.
Table 2
Transition Times (t1, t2), Decay Time Constants (Phase II),






t1 (I = II) (min) 1.3 6 0.4 1.6 6 0.4
Time Constant (II) (min21) 1.24 6 0.33 1.36 6 0.31
t2 (II = III) (min) 3.9 6 0.8 3.9 6 1.1
Reperfusion
t50 (min) 1.8 6 0.7 1.5 6 0.5
t90 (min) 7.8 6 5.9 8.6 6 3.5
Cardiac arrest
t1 (I = II) (min) 1.1 6 0.2 1.2 6 0.1
Time constant (II) (min21) 1.44 6 0.04 1.45 6 0.02
t2 (II = III) (min) 3.2 6 0.2 3.3 6 0.1
*Values characterize the brain water ADCAv responses to transient
global ischemia, reperfusion, and cardiac arrest. For a definition of
phases and times, see Fig. 3. Differences between groups are not
statistically significant (unpaired t tests: Cr-fed rats vs. controls).
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In accordance with the aforementioned series of events,
a putative neuroprotective role of Cr is mainly to be
expected during the early phases of ischemia. Brain uptake
of oral Cr is at least partially followed by phosphorylation
and elevation of the cerebral PCr concentration, which may
delay and/or attenuate ATP depletion during hypoxic/isch-
emic challenge (1–3,5,6). The use of high temporal resolution
allowed us to identify mild trends for a prolonged phase I,
a longer decay time constant during phase II (establish-
ment of the cytotoxic edema), and a less severe total
reduction of ADCAv in Cr-fed rats versus controls. Although
these findings suggest a slightly better performance of the
brain energy status after oral administration of Cr, larger
beneficial effects are to be expected for less severe and/or
focal hypoxic-ischemic challenges or in immature rats.
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